RxPG News Feed for RxPG News

Medical Research Health Special Topics World
  Home
 
   Health
 Aging
 Asian Health
 Events
 Fitness
 Food & Nutrition
 Happiness
 Men's Health
 Mental Health
 Occupational Health
 Parenting
 Public Health
 Sleep Hygiene
 Women's Health
 
   Healthcare
 Africa
 Australia
 Canada Healthcare
 China Healthcare
 India Healthcare
 New Zealand
 South Africa
 UK
 USA
 World Healthcare
 
   Latest Research
 Aging
 Alternative Medicine
 Anaethesia
 Biochemistry
 Biotechnology
 Cancer
 Cardiology
 Clinical Trials
 Cytology
 Dental
 Dermatology
 Embryology
 Endocrinology
 ENT
 Environment
 Epidemiology
 Gastroenterology
 Genetics
 Gynaecology
 Haematology
 Immunology
 Infectious Diseases
 Medicine
 Metabolism
 Microbiology
 Musculoskeletal
 Nephrology
 Neurosciences
 Obstetrics
 Ophthalmology
 Orthopedics
 Paediatrics
 Pathology
 Pharmacology
 Physiology
 Physiotherapy
 Psychiatry
  Anorexia Nervosa
  Anxiety
  Bulimia
  CFS
  Child Psychiatry
  Depression
   Antidepressants
  Forensic Psychiatry
  Learning-Disabilities
  Mood Disorders
  Neuropsychiatry
  Peri-Natal Psychiatry
  Personality Disorders
  Psychology
  Psychoses
  Psychotherapy
  Sleep Disorders
  Substance Abuse
  Suicide
 Radiology
 Rheumatology
 Sports Medicine
 Surgery
 Toxicology
 Urology
 
   Medical News
 Awards & Prizes
 Epidemics
 Launch
 Opinion
 Professionals
 
   Special Topics
 Ethics
 Euthanasia
 Evolution
 Feature
 Odd Medical News
 Climate

Last Updated: Oct 11, 2012 - 10:22:56 PM
Antidepressants Channel

subscribe to Antidepressants newsletter
Latest Research : Psychiatry : Depression : Antidepressants

   EMAIL   |   PRINT
Research shows St. John's Wart as effective as Paroxetine

Feb 11, 2005 - 7:43:00 PM

 
[RxPG] A specially manufactured extract from the herb St John's Wort is at least as effective in treating depression as a commonly prescribed anti-depressant, according to new research published on bmj.com today.

St John's Wort* and the anti-depressant drug Paroxetine** were used in a trial to treat patients with moderate or severe depression. The researchers asked 301 participants of both sexes from German mental health centres to take part in the trial. The two drugs were taken by the patients aged 18-70 over a six week period during 2000 -2003.

At the end of the trial half (61 out of 122) of those who took St John's Wort found their symptoms in decline, whilst only a third (43 out of 122) of those taking Paroxetine went into remission.

Participants also suffered more side-effects by taking Paroxetine with 269 adverse effects being reported over the treatment period. Those taking St John's Wort reported 172 adverse effects – the most common in both cases being stomach disorders.

The authors support the use of St John's Wort as an alternative to treat depression and welcome more research in this area.



Publication: Acute treatment of moderate to severe depression with hypericum extract WS 5570 (St John’s Wort): randomised controlled double blind non-inferiority trial versus paroxetine BMJ Online First
On the web: BMJ-British Medical Journal 

Advertise in this space for $10 per month. Contact us today.


Related Antidepressants News
Antidepressants that are more efficient and faster
Antidepressant Augmentation Can Be Useful in Treatment Resistant Elderly Patients
Certain anti-depressants double fracture risk
STAR*D Trial: Third antidepressant medication might help in treatment-resistant depression
SSRI anti-depressants may cause stillbirth
Anti-depressant use associated with increased risk for heart patients
SSRIs linked with increased risk of persistent pulmonary hypertension in newborns
Antidepressants may affect human immune system
Suicide risk decrease after initiation of antidepressants
'Promiscuous' area of brain could explain role of antidepressants

Subscribe to Antidepressants Newsletter

Enter your email address:


 Additional information about the news article
* Clinical name hypericum extract WS 5570
** Paroxetine is a Selective Serotonin Reuptake Inhibitor (SSRI) drug – a class of anti-depressants
 Feedback
For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 
Contact us

RxPG Online

Nerve

 

    Full Text RSS

© All rights reserved by RxPG Medical Solutions Private Limited (India)